- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07615829
Health Benefits of Dance Exercise
May 22, 2026 updated by: Dimitrios Draganidis, University of Thessaly
Effects of a 6-month Dance Exercise Intervention on Physical Performance, Metabolic and Mental Health in Pre- and Post-menopausal Women
In Greece, people of different age groups, including young children to older adults, participate in dance exercise training.
Although it is well-known that regular participation in dancing is associated with benefits such as entertainment, socialization and increased physical activity, the long-term effects of dancing on metabolic and mental health as well as physical performance remain largely unknown.
Therefore, the aim of this study is to investigate the effects of a 6-month dancing exercise intervention on metabolic and mental health and physical performance in premenopausal and postmenopausal women.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Twenty premenopausal and twenty postmenopausal inactive women meeting the inclusion criteria will be randomly assigned to a Control (n=20) or an Experimental group (n=20).
The Control group will maintain their habitual physical activity level without participating in any form of exercise training.
The Experimental group will participate in two weekly dance exercise training sessions over a 6-month period.
Each session will be performed under supervision and include a 10-min warm up (2-3 dances of very slow tempo), a 45-min main dance exercise session (~15 dances of various tempos i.e. slow, moderate and fast tempo) and a 5-min cool-down period (walking and stretching).
Heart rate will be continuously monitored during each session by using heart rate monitors while the rate of perceived exertion (RPE) will be recorded at the end of each session.
In addition, prior to the second dance exercise session in each week, participants' delayed onset of muscle soreness (DOMS) and wellness status (through the wellness report) will be evaluated.
Prior to (Baseline) and after the intervention period (at 6 months) participants of both groups (Control and Experimental) will undergo resting blood sampling and assessment of their (i) anthropometrics, (ii) body composition, (iii) physical performance, (iv) physical activity level, (v) dietary intake, (vi) quality of life and (vii) mental health.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dimitrios Draganidis, PhD
- Phone Number: +30 2431047047
- Email: ddraganidis@uth.gr
Study Contact Backup
- Name: Ioannis G Fatouros, PhD
- Phone Number: + 30 2431047047
- Email: ifatouros@uth.gr
Study Locations
-
-
Karies
-
Trikala, Karies, Greece, 42100
- Recruiting
- Department of Physical Education and Sport Science, University of Thessaly
-
Contact:
- Ioannis G Fatouros, PhD
- Phone Number: +30 24310 47047
- Email: ifatouros@uth.gr
-
Contact:
- Athanasios Z Jamurtas, PhD
- Phone Number: +30 2431047054
- Email: ajamurt@uth.gr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Free of musculoskeletal injuries
- Free of chronic non-communicable diseases
- Normal menstrual cycle (for premenopausal women)
- No recent childbirth (previous 12 months) (for premenopausal women)
- At least 12 months since the oncet of menopause (for postmenopausal women)
- Non smokers
Exclusion Criteria:
- Pregnancy (for premenopausal women)
- Contraindications to exercise training
- Illness or other medical condition
- Use of medication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group
Participants in this group will maintain their habitual physical activity level without participating in any form of exercise training
|
It will include only habitual physical activity level without participating in any form of exercise training
|
|
Experimental: Experimental Group
Participants in this group will participate in two weekly dance exercise training sessions over a 6-month period
|
This intervention will consist of two weekly dance exercise training sessions over a 6-month period.
Each session will be performed under supervision and include a 10-min warm up (2-3 dances of very slow tempo), a 45-min main dance exercise session (~15 dances of various tempos i.e. slow, moderate and fast tempo) and a 5-min cool-down period (walking and stretching)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in glucose concentration
Time Frame: At baseline and 6 months
|
Fasting glucose concentration will be determined in blood
|
At baseline and 6 months
|
|
Change in insulin concentration
Time Frame: At baseline and 6 months
|
Fasting insulin concentration will be determined in blood
|
At baseline and 6 months
|
|
Change in total cholesterol concentration
Time Frame: At baseline and 6 months
|
Total cholesterol concentration will be determined in blood
|
At baseline and 6 months
|
|
Change in HDL cholesterol concentration
Time Frame: At baseline and 6 months
|
HDL cholesterol concentration will be determined in blood
|
At baseline and 6 months
|
|
Change in LDL cholesterol concentration
Time Frame: At baseline and 6 months
|
LDL cholesterol concentration will be determined in blood
|
At baseline and 6 months
|
|
Change in triglycerides concentration
Time Frame: At baseline and 6 months
|
Triglycerides concentration will be determined in blood
|
At baseline and 6 months
|
|
Change in serum glutamic-oxaloacetic transaminase (SGOT/AST) concentration
Time Frame: At baseline and 6 months
|
SGOT concentration will be determined in blood
|
At baseline and 6 months
|
|
Change in alanine aminotransferase (SGPT/ALT) concentration
Time Frame: At baseline and 6 months
|
SGPT concentration will be determined in blood
|
At baseline and 6 months
|
|
Change in gamma-glutamyl transpeptidase (γ-GT) concentration
Time Frame: At baseline and 6 months
|
γ-GT concentration will be determined in blood
|
At baseline and 6 months
|
|
Change in body weight
Time Frame: At baseline and 6 months
|
At baseline and 6 months
|
|
|
Change in waist circumference
Time Frame: At baseline and 6 months
|
At baseline and 6 months
|
|
|
Change in hip circumference
Time Frame: At baseline and 6 months
|
At baseline and 6 months
|
|
|
Change in fat mass
Time Frame: At baseline and 6 months
|
Fat mass will be assessed by using whole-body dual-energy X-ray absorptiometry (DXA)
|
At baseline and 6 months
|
|
Change in body fat percentage (%)
Time Frame: At baseline and 6 months
|
Body fat percentage (%) will be assessed by using whole-body dual-energy X-ray absorptiometry (DXA)
|
At baseline and 6 months
|
|
Change in fat free mass
Time Frame: At baseline and 6 months
|
Fat free mass will be assessed by using whole-body dual-energy X-ray absorptiometry (DXA)
|
At baseline and 6 months
|
|
Change in lean body mass
Time Frame: At baseline and 6 months
|
Lean body mass will be assessed by using whole-body dual-energy X-ray absorptiometry (DXA)
|
At baseline and 6 months
|
|
Change in cardiorespiratory fitness
Time Frame: At baseline and 6 months
|
Cardiorespiratory fitness will be assessed using the Ebbeling single stage treadmill test
|
At baseline and 6 months
|
|
Change in functional performance
Time Frame: At baseline and 6 months
|
Functional performance will be assessed using the Short Physical Perforamnce Battery
|
At baseline and 6 months
|
|
Change in muscle endurance
Time Frame: At baseline and 6 months
|
Muscle endurance will be assessed using the push-up and curl-up testing protocols
|
At baseline and 6 months
|
|
Change in resting blood pressure
Time Frame: At baseline and 6 months
|
Resting systolic and diastolic blood pressure will be assessed using a sphygmomanometer
|
At baseline and 6 months
|
|
Change in quality of life
Time Frame: At baseline and 6 months
|
Quality of life will be evaluated using questionnaire
|
At baseline and 6 months
|
|
Change in vitality
Time Frame: At baseline and 6 months
|
Vitality will be evaluated using questionnaire
|
At baseline and 6 months
|
|
Change in anxiety level
Time Frame: At baseline and 6 months
|
Anxiety will be evaluated using questionnaire
|
At baseline and 6 months
|
|
Change in flourishing
Time Frame: At baseline and 6 months
|
Flourishing will be evaluated using questionnaire
|
At baseline and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in dietary intake
Time Frame: At baseline and 6 months
|
Dietary intake will be monitored using diet recalls
|
At baseline and 6 months
|
|
Change in daily number of steps
Time Frame: At baseline and 6 months
|
Daily number of steps performed will be assessed by using accelerometers
|
At baseline and 6 months
|
|
Change in daily time spent in moderate-to-vigorous physical activity
Time Frame: At baseline and 6 months
|
The time spent in moderate-to-vigorous physical activity will be assessed by using accelerometers
|
At baseline and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Maria Bougiesi, PhD, University of Thessaly, Department of Physical Education and Sport Science
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 30, 2026
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
December 20, 2026
Study Registration Dates
First Submitted
May 22, 2026
First Submitted That Met QC Criteria
May 22, 2026
First Posted (Actual)
May 29, 2026
Study Record Updates
Last Update Posted (Actual)
May 29, 2026
Last Update Submitted That Met QC Criteria
May 22, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UTH_2251_Long term
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health
-
Sanctuary Mental Health MinistriesExcellence in Giving InsightsNot yet recruitingMental Health | Mental Health Help-Seeking | Mental Health LiteracyUnited States
-
Neslihan LokCompletedAdolescent | Mental Health | Mental Health Care | Mental Health ConditionsTurkey
-
GCS-CCOMSINSERM ECEVE 1123; L'Assistance Publique - Hopitaux de Paris (AP-HP)Active, not recruitingRecovery | Organization of Health Service | Mental Health Services | Mental Health CareFrance
-
King's College LondonCompletedMental Health Wellness 1 | Mental Health IssueUnited Kingdom
-
Universidad Metropolitana de Ciencias de la EducacionNot yet recruitingMental Health | Physical Inactivity | Cardiovascular Health | Mental Health Care | Sedentary BehaviorsChile
-
VA Office of Research and DevelopmentCompletedMental Health | Veterans Health | Rural HealthUnited States
-
Cambridge Health AllianceNot yet recruitingMental Health | Adolescent Health | Minority Health | Community Health Services
-
Chapin Hall at the University of ChicagoUniversity of ConnecticutCompletedMental Health | Physical Health
-
Chinese University of Hong KongRecruitingMental Health Wellness 1 | Mental Well-being | Mental Health Issue | Precision Mental HealthHong Kong
-
Chinese University of Hong KongThe University of Hong Kong; The Hong Kong Polytechnic University; The Hong Kong... and other collaboratorsRecruitingMental Well-being | Adolescent Health | Mental Health Help-Seeking | Mental Health Literacy | School Difficulties Associated With Mental Health ProblemsHong Kong
Clinical Trials on No exercise training
-
University Hospital, Strasbourg, FranceCompleted
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedCongenital Heart Disease | Univentricular Heart | Single VentricleBrazil
-
Rigshospitalet, DenmarkCompleted
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedDiabetes Mellitus, Type 2Norway
-
Nova Scotia Health AuthorityCapital Health, CanadaCompleted
-
University of MinnesotaCompleted
-
Università degli Studi di FerraraCompleted
-
Istinye UniversityCompletedGastro Esophageal Reflux | Pilates ExerciseTurkey (Türkiye)
-
Rigshospitalet, DenmarkCompletedRheumatoid ArthritisDenmark
-
Çağtay MadenCompletedSedentary Behavior | Gaming DisorderTurkey